NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-096-2017-0-PCT-02 NEXT-GENERATION SEQUENCING-BASED GENOTYPING ASSAY FOR HUMAN PAPILLOMA VIRUS (HPV) PCT PCT PCT/US16/033437 Expired
NHLBI E-045-2019-0-US-01 Free Breathing Motion Corrected Pixel-wise Mri Myocardial T1 Parameter Mapping US ORD 15/155,205 10264994 Issued PDF
NHGRI E-007-1999-2-JP-11 Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers JP DIV 2016-97711 Expired
NINR E-134-2015-0-PCT-02 POINT OF NEED TESTING DEVICE AND METHODS OF USE THEREOF PCT PCT PCT/US16/032788 Expired
NCI E-087-2015-1-FR-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs FR EP 16725323.6 Issued
NCI E-087-2015-1-DE-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs DE EP 16725323.6 Issued
NCI E-087-2015-1-CH-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs CH EP 16725323.6 Issued
NCI E-087-2015-1-GB-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs GB EP 16725323.6 Issued
NCI E-087-2015-1-EP-02 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs EP National Stage 16725323.6 Issued
NCI E-087-2015-1-ES-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs ES EP 16725323.6 Issued
NIDDK E-064-2004-0-US-58 The Use Of Leptin For Treating Human Lipotrophy US CON 15/154,749 Abandoned
NHLBI E-516-2013-0-US-03 Detection of Atherosclerotic Cardiovascular Disease Risk US National Stage 15/036,751 Abandoned
NCI E-771-2013-4-CN-10 Modified Pseudomonas Exotoxin A CN National Stage 201480062185.7 Issued
NCI E-087-2015-1-PCT-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs PCT PCT COMB PCT/US16/032317 Expired
NIDCR E-175-2015-1-GB-09 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone GB EP 16727258.2 Issued
NIDCR E-175-2015-1-DE-07 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone DE EP 16727258.2 Issued
NIDCR E-175-2015-1-FR-08 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone FR EP 16727258.2 Issued
NIDCR E-175-2015-1-EP-03 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone EP National Stage 16727258.2 Issued
NIDCR E-175-2015-1-PCT-01 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone PCT PCT COMB PCT/US2016/032047 Expired
NCI E-179-2015-0-PCT-02 Methods for the Treatment or Prevention of Ischemic Tissue Damage PCT PCT PCT/US2016/032194 Abandoned
NCI E-178-2015-0-PCT-02 Synthetic Immunosuppressive Oligodeoxynucleotides Reduce Ischemic Tissue Damage PCT PCT PCT/US2016/032192 Abandoned
NCATS E-751-2013-0-US-03 Method of Blocking Transmission of Malarial Parasite US National Stage 15/036,355 Abandoned
NIDCR E-175-2015-1-CA-02 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone CA National Stage 2985786 Issued
NCI E-029-2006-1-AU-14 N-Substituted indenoisoquinolines and syntheses thereof AU DIV 2016203107 Abandoned
NIAMS E-762-2013-1-US-02 Engineering Neural Stem Cells using Homologous Recombination US National Stage 15/035,958 9951353 Issued PDF
NCI E-113-2016-0-US-01 Variable New Antigen Receptor (VNAR) Antibodies and Antibody Conjugates Targeting Tumor and Viral Antigens US 62/334,194 Abandoned
NHLBI E-078-2015-0-CN-05 Three-Dimensional Right Atrial Appendage Curve Catheter CN National Stage 201680027776.X Issued
NHLBI E-078-2015-0-PCT-02 Three-Dimensional Right Atrial Appendage Curve Catheter PCT PCT PCT/US2016/031461 Expired
NHLBI E-078-2015-0-EP-03 Three-Dimensional Right Atrial Appendage Curve Catheter EP National Stage 16796939.3 Pending
NIBIB E-150-2016-0-US-01 Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents US 62/333,427 Abandoned
NCI E-750-2013-0-US-09 Method For Subtyping Lymphoma Types by Means of Expression Profiling US National Stage 15/035,101 10607717 Issued PDF
NCI E-750-2013-0-JP-07 Methods for Subtyping Lymphoma Types by Means of Expression Profiling JP National Stage 2016-553231 Issued
NIEHS E-179-2016-0-US-01 Novel Strategy To Increase Drug Delivery To The Brain US 62/332,888 Abandoned
NHLBI E-201-2016-0-US-01 Annuloplasty Procedures, Related Devices And Methods US 62/332,754 Abandoned
NHLBI E-155-2016-0-US-01 LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES US 62/332,277 Abandoned
NHLBI E-259-2007-0-US-05 Nitrite And Nitrite-methemoglobin Therapy To Detoxify Stroma-free Hemoglobin Based Blood Substitutes US CON 15/146,190 Abandoned
NIDCR E-122-2016-0-US-01 Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone US 62/331,699 Abandoned
NIBIB E-149-2016-0-US-01 Albumin-binding Immunodulatory Compositions And Methods Of Use Thereof US 62/331,890 Abandoned
NIAID E-004-2009-2-US-15 METHODS FOR THE INDUCTION OF IMMUNE RESPONSES IN A SUBJECT COMPRISING ADMINISTERING VIRUS-LIKE PARTICLES (VLPS) PREPARED FROM CHIKUNGUNYA VIRUS STRUCTURAL PROTEINS US DIV 15/145,483 10369208 Issued PDF
NCI E-007-2014-0-US-04 ALK Antibodies, Conjugates, and Chimeric Antigen Receptors, and Their Use US National Stage 15/034,171 Abandoned
NIAID E-052-2017-3-US-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection US 62/331,169 Abandoned
NHLBI E-156-2016-0-US-01 Derivation Of A Greater Than 25 Million-year-old Adeno-associated Virus Coat Protein Sequence US 62/331,188 Abandoned
NIAID E-061-2016-0-US-01 NEUTRALIZING ANTIBODIES TO INFLUENZA HA AND THEIR USE AND IDENTIFICATION US 62/330,837 Abandoned
NCI E-171-2018-4-US-01 INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY US 62/330,464 Abandoned
NCI E-149-2015-0-CA-04 Methods of Isolating T Cells and T Cell Receptors Having Antigen Specificaity for a Cancer-Specific Mutation from Peripheral Blood CA National Stage 2984234 Issued
NCI E-262-2005-0-AU-31 Mutated Pseudomonas Exotoxins with Reduced Antigenicity AU DIV 2016202754 Issued
NIBIB E-135-2015-0-PCT-02 Organotrifluoroborate Mimics of Amino Acids and Uses Thereof PCT PCT PCT/US2016/030106 Expired
NIAID E-141-2015-0-PCT-02 Preventing or Treating Viral Infection by Inhibition of the Histone Methyltransferase EZH1 or EZH2 PCT PCT PCT/US16/030089 Expired
NCI E-149-2015-0-PCT-02 Methods of Isolating T Cells and T Cell Receptors Having Antigen Specificaity for a Cancer-Specific Mutation from Peripheral Blood PCT PCT PCT/US16/030137 Expired
NEI E-171-2016-0-US-01 NADPH Oxidase Contributes to Photoreceptor Degeneration US 62/329,758 Abandoned